Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 1, 2000, Pages 51-60

  Abe, Shuichi ^a,b,c   Nakamura, Hidenori ^a,b,c   Inoue, Sumito ^a,b,c   Takeda, Hiroaki ^a,b,c   Saito, Hiroshi ^a,b,c   Kato, Shuichi ^a,b,c   Mukaida, Naofumi ^a,b,c   Matsushima, Kouji ^a,b,c   Tomoike, Hitonobu ^a,b,c  

^a YAMAGATA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS;

EID: 0034035777     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.1.3400     Document Type: Article

References (59)

1. 1. Koyama, H., and D. M. Geddes. 1997. Erythromycin and diffuse panbronchiolitis. Thorax 52:915-918.
2. 2. Kudoh, S., T. Uetake, K. Hagiwara, M. Hirayama, L. H. Hus, H. Kimura, and Y. Sugiyama. 1987. Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn. J. Thorac Dis. 25: 632-642.
3. 3. Fujii, T., J. Kadota, K. Kawakami, K. Iida, R. Shirai, M. Kaseda, S. Kawamoto, and S. Kohno. 1995. Long-term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50:1246-1252.
4. 4. Oishi, K., F. Sonoda, S. Kobayashi, A. Iwagaki, T. Nagatake, K. Matsushima, and K. Matsumoto. 1994. Role of interleukin-8 (IL)-8 and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 62:4145-4152.
5. 5. Kadota, J., O. Sakito, S. Kohno, H. Sawa, H. Mukae, H. Oda, K. Kawakami, K. Fukushima, K. Hiratani, and K. Hara. 1993. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147:153-159.
6. 6. Sawaki, M., R. Mikami, K. Mikasa, M. Kunimatsu, S. Ito, and N. Narita. 1986. The long term chemotherapy with erythromycin in chronic lower respiratory tract infections - second report: including cases with Pseudomonas infections. Jpn. Assoc. Infect. Dis. 60:45-50.
7. 7. Miyatake, H., F. Taki, H. Taniguchi, R. Suzuki, K. Takagi, and T. Satake. 1991. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99:670-673.
8. 8. Konno, S., K. Asano, M. Kurokawa, K. Ikeda, K. Okamoto, and M. Adachi. 1994. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int. Arch. Allergy Immunol. 105:308-316.
9. 9. Takizawa, H., M. Desaki, T. Ohtoshi, S. Kawasaki, T. Kohyama, M. Sato, M. Tanaka, T. Kasama, K. Kobayashi, J. Nakajima, and K. Ito. 1997. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 156:266-271.
10. 10. Yanagihara, K., K. Tomono, T. Sawai, Y. Hirakata, J. Kadota, H. Koga, T. Tashiro, and S. Kohno. 1997. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 155:337-342.
11. 11. Takeda, H., H. Miura, M. Kawahira, H. Kobayashi, S. Otomo, and S. Nakaike. 1989. Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis. J. Jpn. Assoc. Infect. Dis. 63:71-78.
12. 12. Kadota, J., O. Sakito, S. Konno, K. Abe, R. Shirai, K. Kawakami, K. Iida, T. Morikawa, S. Kusano, and K. Hara. 1994. Roxithromycin treatment in patients with chronic lower respiratory tract disease - its clinical efficacy and effect on cytokine. J. Jpn. Assoc. Infect. Dis. 68:27-33.
13. 13. Nelson, S., W. R. Summer, P. B. Terry, G. A. Warr, and G. J. Jakab. 1987. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am. Rev. Respir. Dis. 136:1207-1212.
14. 14. Ichikawa, Y., H. Ninomiya, H. Koga, M. Tanaka, M. Kinoshita, N. Tokunaga, T. Yano, and K. Oizumi. 1992. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev. Respir. Dis. 146:196-203.
15. 15. Tamaoki, J., E. Tagaya, I. Yamawaki, N. Sakai, A. Nagai, and K. Konno. 1995. Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs. Am. J. Respir. Crit. Care Med. 151:1582-1588.
16. 16. Iino, Y., M. Toriyama, K. Kudo, Y. Natori, and A. Yuo. 1992. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann. Otol. Rhinol. Laryngol. 157(Suppl.):16-20.
17. 17. Khair, O. A., J. L. Devalia, M. M. Abdelaziz, R. J. Sapsford, and R. J. Davies. 1995. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur. Respir. J. 8:1451-1457.
18. 18. Takizawa, H., M. Desaki, T. Ohtoshi, T. Kikutani, H. Okazaki, M. Sato, N. Akiyama, S. Shoji, K. Hiramatsu, and K. Ito. 1995. Erythromycin suppresses interleukin-6 expression by human bronchial epithelial cells: a potential mechanism of its antiinflammatory action. Biochem. Biophys. Res. Commun. 210:781-786.
19. 19. Keicho, N., S. Kudoh, H. Yotsumoto, and K. S. Akagawa. 1993. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J. Antibiot. (Tokyo) 46:1406-1413.
20. 20. Poon, M., S. O. Marx, R. Gallo, J. J. Badimon, M. B. Taubman, and A. R. Marks. 1996. Rapamycin inhibits vascular smooth-muscle cell migration. J. Clin. Invest. 98:2277-2283.
21. 21. Yoshimura, T., K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim, and E. J. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA. 84:9233-9237.
22. 22. Matsushima, K., K. Morishita, T. Yoshimura, S. Lavu, Y. Kobayashi, W. Lew, E. Appella, H. F. Kung, E. J. Leonard, and J. J. Oppenheim. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J. Exp. Med. 167:1883-1893.
23. 23. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
24. 24. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch III, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
25. 25. Nakamura, H., K. Yoshimura, H. A. Jaffe, and R. G. Crystal. 1991. Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266:19611-19617.
26. 26. Nakamura, H., K. Yoshimura, N. G. McElvaney, and R. G. Crystal. 1992. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89:1478-1484.
27. 27. Shibata, Y., H. Nakamura, S. Kato, and H. Tomoike. 1996. Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells. J. Immunol. 156:772-777.
28. 28. Richman, E. J., P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am. J. Physiol. 264:L413-L418.
29. 29. Sakito, O., J. Kadota, S. Kohno, K. Abe, R. Shirai, and K. Hara. 1996. Interleukin-1 beta, tumor necrosis factor-alpha, and interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63:42-48.
30. 30. Stadnyk, A. W. 1994. Cytokine production by epithelial cells. FASEB J. 8:1041-1047.
31. 31. Levine, S. J. 1995. Bronchial epithelial cell-cytokine interactions in airway inflammation. J. Invest. Med. 43:241-249.
32. 32. Reddel, R. R., Y. Ke, B. I. Gerwin, M. G. McMenamin, J. F. Lechner, R. T. Su, D. E. Brash, J. B. Park, J. S. Rhim, and C. C. Harris. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecapitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1904-1909.
33. 33. Leehner, J. F., and M. A. LaVeck. 1985. A serum-free method fur culturing normal human bronchial epithelial cells at clonal density. J. Tissue Culture Methods 9:43-48.
34. 34. Fish, D. N., M. H. Gotfried, L. H. Danziger, and K. H. Rodvold. 1994. Penetration of clarithromycin into lung tissues from patients undergoing lung resection. Antimicrob. Agents Chemother. 38:876-878.
35. 3H-thymidine incorporation assay. J. Clin. Lab. Anal. 9:89-95.
36. 36. Ausubel, F. M., R. Brent, E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1993. Analysis of RNA by Northern and slot-blot hybridization. In Current Protocols in Molecular Biology. John Wiley & Sons, New York. 4.9.1-4.9.14.
37. 37. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
38. 38. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
39. 39. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
40. 40. Nakamura, H., T. Hino, S. Kato, Y. Shibata, H. Takahashi, and H. Tomoike. 1996. Tumour necrosis factor receptor gene expression and shedding in human whole lung tissue and pulmonary epithelium. Eur. Respir. J. 9:1643-1647.
41. 41. Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143:1366-1371.
42. 42. Aihara, M., D. Tsuchimoto, H. Takizawa, A. Azuma, H. Wakebe, Y. Ohmoto, K. Imagawa, M. Kikuchi, N. Mukaida, and K. Matsushima. 1997. Mechanisms involved in Helicobactor pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect. Immun. 65:3218-3224.
43. 43. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417.
44. 44. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
45. 45. Wong, H. R., M. Ryan, and J. R. Wispe. 1997. Stress response decreases NF-κB nuclear translocation and increases Iκ-Bα expression in A549 cells. J. Clin. Invest. 99:2423-2428.
46. 46. Mukaida, N., S. Okamoto, Y. Ishikawa, and K. Matsushima. 1994. Molecular mechanism of inlerleukin-8 gene expression. J. Leukoc. Biol. 56:554-558.
47. 47. Kowalski, J., and D. T. Denhardt. 1989. Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyclocytes. Mol. Cell Biol. 9:1946-1957.
48. 48. Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucucorticoids downregulate gene expression of GM-CSF, NAP-I/ IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45-51.
49. 49. Villarete, L. H., and D. G. Remick. 1996. Transcriptional and post-transcriptional regulation of interleukin-8. Am. J. Pathol. 149:1685-1693.
50. 50. Mukaida, N., Y. Mahe, and K. Matsushima. 1990. Cooperative interaction of nuclear factor-κB-and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:21128-21133.
51. 51. Mahe, Y., N. Mukaida, K. Kuno, M. Akiyama, N. Ikeda, K. Matsushima, and S. Murakami. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor-κB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266:13759-13763.
52. 52. Kunsch, C., R. K. Lang, C. A. Rosen, and M. F. Shannon. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153:153-164.
53. 53. Yasumoto, K., S. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin-8 gene. J. Biol. Chem. 267:22506-22511.
54. 54. Lee, L. F., J. S. Haskill, N. Mukaida, K. Matsushima, and J. P. Ting. 1997. Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol. Cell. Biol. 17:5097-5105.
55. 55. Okamoto, S., N. Mukaida, K. Yasumoto, N. Rice, Y. Ishikawa, H. Horiguchi, S. Murakami, and K. Matsushima. 1994. The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J. Biol. Chem. 269:8582-8589.
56. 56. Mukaida, N., G. L. Gussella, T. Kasahara, Y. Ko, C. O. Zachariae, T. Kawai, and K. Matsushima. 1992. Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line. Immunology 75:674-679.
57. 57. Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289-13295.
58. 58. Oliveira, I. C., N. Mukaida, K. Matsushima, and J. Vilcek. 1994. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol. Cell. Biol. 14:5300-5308.
59. 59. Ye, J., and H. A. Young. 1997. Negative regulation of cytokine gene transcription. FASEB J. 11:825-833.